A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis

K. A. Papp; K. Reich; C. Paul; A. Blauvelt; W. Baran; C. Bolduc; D. Toth; R. G. Langley; J. Cather; A. B. Gottlieb; D. Thaçi; J. G. Krueger; C. B. Russell; C. E. Milmont; J. Li; P. A. Klekotka; G. Kricorian; A. Nirula

doi:10.1111/bjd.14493

A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis

K. A. Papp, K. Reich, C. Paul, A. Blauvelt, W. Baran, C. Bolduc, D. Toth, R. G. Langley, J. Cather, A. B. Gottlieb, D. Thaçi, J. G. Krueger, C. B. Russell, C. E. Milmont, J. Li, P. A. Klekotka, G. Kricorian, A. Nirula

Inernational Relations Division

科研成果: 期刊稿件 › 文章 › 同行评审

404 引用（Scopus）

源语言	英语
页（从-至）	273-286
页数	14
期刊	British Journal of Dermatology
卷	175
期	2
DOI	https://doi.org/10.1111/bjd.14493
出版状态	已出版 - 2016

!!!ASJC Scopus Subject Areas

皮肤医学

访问文件

10.1111/bjd.14493

其它文件与链接

引用此

Papp, K. A., Reich, K., Paul, C., Blauvelt, A., Baran, W., Bolduc, C., Toth, D., Langley, R. G., Cather, J., Gottlieb, A. B., Thaçi, D., Krueger, J. G., Russell, C. B., Milmont, C. E., Li, J., Klekotka, P. A., Kricorian, G., & Nirula, A. (2016). A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis. British Journal of Dermatology, 175(2), 273-286. https://doi.org/10.1111/bjd.14493

Papp, KA, Reich, K, Paul, C, Blauvelt, A, Baran, W, Bolduc, C, Toth, D, Langley, RG, Cather, J, Gottlieb, AB, Thaçi, D, Krueger, JG, Russell, CB, Milmont, CE, Li, J, Klekotka, PA, Kricorian, G & Nirula, A 2016, 'A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis', British Journal of Dermatology, 卷 175, 号码 2, 页码 273-286. https://doi.org/10.1111/bjd.14493

@article{223f04b93cbb403da3e84f513fd28861,

title = "A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis",

author = "Papp, {K. A.} and K. Reich and C. Paul and A. Blauvelt and W. Baran and C. Bolduc and D. Toth and Langley, {R. G.} and J. Cather and Gottlieb, {A. B.} and D. Tha{\c c}i and Krueger, {J. G.} and Russell, {C. B.} and Milmont, {C. E.} and J. Li and Klekotka, {P. A.} and G. Kricorian and A. Nirula",

note = "Publisher Copyright: {\textcopyright} 2016 The Authors. British Journal of Dermatology published by John Wiley & Sons Ltd on behalf of British Association of Dermatologists.",

year = "2016",

doi = "10.1111/bjd.14493",

language = "English",

volume = "175",

pages = "273--286",

journal = "British Journal of Dermatology",

issn = "0007-0963",

publisher = "Wiley-Blackwell",

number = "2",

}

TY - JOUR

T1 - A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis

AU - Papp, K. A.

AU - Reich, K.

AU - Paul, C.

AU - Blauvelt, A.

AU - Baran, W.

AU - Bolduc, C.

AU - Toth, D.

AU - Langley, R. G.

AU - Cather, J.

AU - Gottlieb, A. B.

AU - Thaçi, D.

AU - Krueger, J. G.

AU - Russell, C. B.

AU - Milmont, C. E.

AU - Li, J.

AU - Klekotka, P. A.

AU - Kricorian, G.

AU - Nirula, A.

PY - 2016

Y1 - 2016

UR - http://www.scopus.com/inward/record.url?scp=84988039700&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84988039700&partnerID=8YFLogxK

U2 - 10.1111/bjd.14493

DO - 10.1111/bjd.14493

M3 - Article

C2 - 26914406

AN - SCOPUS:84988039700

SN - 0007-0963

VL - 175

SP - 273

EP - 286

JO - British Journal of Dermatology

JF - British Journal of Dermatology

IS - 2

ER -

A prospective phase III, randomized, double-blind, placebo-controlled study of brodalumab in patients with moderate-to-severe plaque psoriasis

!!!ASJC Scopus Subject Areas

访问文件

其它文件与链接

指纹

引用此